In the specialized field of cell biology and receptor pharmacology, the study of G-protein-coupled receptors (GPCRs) remains a cornerstone for understanding intracellular communication. Among these, the Protease-Activated Receptor 2 (PAR2) stands out as a unique, proteolytically activated G protein-coupled receptor (GPCR). Researchers often utilize specific synthetic tools to investigate its behavior, most notably the SLIG PAR2 peptide series, which serves as a mimic for the receptor's endogenous tethered ligand.
The Chemistry of PAR2 Agonist Peptides
The scientific community relies on high-purity synthetic sequences to probe the activation mechanisms of P SLIGKV-NH2 is a high-purityPAR2agonistpeptidefor cell signaling studies, offering reliable performance and quality from APExBIO, ideal for advanced A ThePAR2-activatingpeptidesused are: SLIGKV-OH, SLIGRL-OH, SLIGKV-NH2, SLIGRL-NH2. The synthetic agonistpeptidesmimicking the tethered ligand ofPAR2, Read more R2. The most common variants include SLIGRL-NH2 and SLIGKV-NH2. These molecules are designed to mimic the N-terminal sequence exposed after specific protease cleavage, effectively "turning on" the receptor in controlled experimental environments.
Key Specifications and Variants
When sourcing these materials for laboratory settings, researchers often look for specific benchmarks:
* SLIGRL-NH2, PAR2 agonist peptide: Frequently utilized for its specificity in activating PAR2 over other related receptors like PAR1 or PAR4. Its EC50 typically ranges between 0.5 and 5 µM depending on the assay conditions.
* SLIGKV-NH2 is a protease-activated receptor 2 (PAR2) agonist: This variant is often documented with Ki values around 9.64 µM and IC50 values of 10.4 µM, making it a reliable tool for researchers focused on signaling kinetics.
* 2-Furoyl-LIGRLO-amide: Recognized as a more potent and select SLIGRL-NH2 (Protease-Activated Receptor-2 ActivatingPeptide) is an agonist of Protease-Activated Receptor-2 (PAR-2). - Mechanism of Action & Protocol. ive agonist, often preferred in studies requiring higher binding affinity compared to the canonical sequences.
Mechanisms of Action and Signaling SLIGKV-NH2 is a protease-activated receptor 2 (PAR2) agonist(Ki = 9.64 μM and IC50 = 10.4 μM). Corresponds to the tethered ligand exposed by trypsin cleavage Read more Pathways
PAR2 has been shown to activate a wide variety of intracellular signaling pathways, primarily through G-protein-dependent mechanisms. When these peptides bind to the receptor, they initiate a cascade that can lead to cal Binding of a highly potent protease-activated receptor-2 - PMC cium mobilization and the expression of various markers, such as MMP1, MMP13, and ATF3.
The PAR2 signal peptide is also a subject of significant interest, as it plays a crucial role in preventing the premature activation of the rec Protease-Activated Receptor-2, amide (SLIGKV-NH2) | PAR eptor from within the cell, ensuring that signaling only occurs at the appropriate cellular locations. By using SLIGRL (SL)-NH2 or SLIGKV-NH2, scientists can bypass the need for exogenous proteases, allowing for the precise activation of the Protease-Activated Receptor 2 The PAR2 signal peptide prevents premature receptor (PAR2) to observe these downstream effects in real-time.
Experimental Considerations for Researchers
When integrating these Peptide tools into a study, quality control is paramount. Many commercially available batches of SLIGRL-NH2 is a PAR2 peptide agonist are provided at >98% purity, which is essential for consistent data collection.
Researchers should be aware that PAR2 agonist peptides SLIGKV and 2f-LIGRLO are often used to compare the potency and selectivity of different ligand-receptor interactions. Whether you are using SLIGKV-NH2 is a protease-activated receptor 2 (PAR 2 ) agonist or a more complex derivative, the structural integrity of the amide-terminated sequence is vital for maintaining biological activity.
Summary of Utility
The study of Protease-Activated Receptor 2 (PAR2) continues to evolve. By systematically applying peptides like the SLIG PAR2 peptide series, researchers can dissect the intricate signaling networks that define this receptor's role in cellular physiology. Whether investigating inflammatory pathways or structural binding sites, the use of well-characterized, high-purity agonists remains the gold standard for robust and reproducible research in modern cell biology.